Related Experiment Video
Updated: Jan 11, 2026

05:16
Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021
3.7K
Shared Biomarkers and Potential Mechanisms Between Hashimoto's Thyroiditis and Recurrent Miscarriage Revealed by
Zengmei Cheng1, Shuyun Zhao2, Lu Yang1
1Department of Obstetrics and Gynecology, Guizhou Medical University, Guiyang, Guizhou, People's Republic of China.
International Journal of General Medicine
|November 11, 2025
Summary
Common biomarkers CFL1 and TRAPPC1 link Hashimoto's thyroiditis (HT) and recurrent miscarriage (RM). This study identifies shared molecular mechanisms and immune microenvironment characteristics, offering potential diagnostic and therapeutic targets for these conditions.
Area of Science:
- Endocrinology and Immunology
- Reproductive Medicine
- Bioinformatics
Background:
- Hashimoto's thyroiditis (HT) is increasingly linked to recurrent miscarriage (RM), but underlying mechanisms remain unclear.
- Identifying shared biomarkers is crucial for understanding the association between HT and RM.
- This research focuses on elucidating the molecular and immunological connections between these two conditions.
Purpose of the Study:
- To identify key shared biomarkers between Hashimoto's thyroiditis and recurrent miscarriage using bioinformatics.
- To reveal potential molecular mechanisms and immune microenvironment characteristics associated with these shared biomarkers.
- To provide a theoretical basis and potential targets for diagnosing and treating the link between HT and RM.
Main Methods:
- Integrated transcriptomic analysis of HT thyroid and RM endometrial tissue datasets from the Gene Expression Omnibus (GEO) database.
- Identification of differentially expressed genes (DEGs) and candidate biomarkers through protein-protein interaction (PPI) network analysis.
- Gene Set Enrichment Analysis (GSEA) for pathway analysis and ssGSEA for immune cell infiltration quantification, followed by molecular docking for drug prediction.
Main Results:
- Cofilin-1 (CFL1) and TRAPPC1 were identified as significant biomarkers, upregulated in both HT and RM.
- Biomarkers were enriched in pathways including "autoimmune thyroid disease" and "antigen processing and presentation".
- Significant differences in monocyte and eosinophil infiltration were observed, correlating with biomarker expression, and potential therapeutic drugs were predicted.
Conclusions:
- CFL1 and TRAPPC1 serve as common biomarkers for Hashimoto's thyroiditis and recurrent miscarriage.
- These findings offer novel insights for fundamental research and early clinical diagnosis and treatment strategies.
- The study provides a foundation for further investigation into the pathogenesis and therapeutic interventions for the HT-RM association.
Related Concept Videos
Synthesis and Regulation of Thyroid Hormones
7.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K
Non-LTR Retrotransposons
13.1K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.1K

